Editas Medicine History - Founding, Milestones & Growth Journey

History

Year	Detail
2013	Editas Medicine was founded under “Gengine, Inc." in September 2013 by Feng Zhang of the Broad Institute.
2023	Editas Medicine and Vertex Pharmaceuticals entered a license agreement for Cas9 for CASGEVY (exagamglogene autotemcel).
2024	Editas Medicine and Bristol Myers Squibb extend the collaboration of Alpha-Beta T Cell.

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.